hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

In this letter to the editor, the authors discuss the use of human equilibrative nucleoside transporter 1 (hENT-1) as a biomarker in patients with cholangiocarcinoma. They encourage standardization of techniques to evaluation expression of proteins such as hENT-1 and suggest additional studies inves...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Meijer, Laura L., Puik, Jisce R., Peters, Godefridus J., Kazemier, Geert, Giovannetti, Elisa
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2016
Témata:
Letters to the Editor
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153344/
https://ncbi.nlm.nih.gov/pubmed/27807304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0262
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky